S

Does Obesity Make Leukemia Harder to Cure? Can A Caloric and Nutrient Restriction Augment Chemotherapy Efficacy for Acute Lymphoblastic Leukemia?

By Steven Mittelman
0 views
May 16, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

24:08
Indy Hematology Review

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Feat. A. Tefferi

Recommended

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
10:23
Columbia University Institute of Human Nutrition

Overnight Oats and Oat Bites: Columbia / IHN Breast Cancer Awareness…

Feat. O. Weinstein
21:05
Louisville Hematology Highlights

Why Are Our Hematopoietic Stem Cells in the Bone Marrow?

Feat. R. Gale
22:37
Insights from 2023 ASH Annual Meeting

AML and MDS Highlights & Key Takeaways

Feat. T. Badar
44:47
Scripps Health

Nutrition + Supplements in Cancer: Do's and Don'ts

Feat. D. Abrams
10:40
Columbia University Institute of Human Nutrition

Tofu Bites and Tofu Pudding: Columbia / IHN Breast Cancer Awareness …

Feat. O. Weinstein
24:44
Indy Hematology Review

State of the Art in 2024: Emerging Therapies in Hematologic Malignan…

Feat. R. Birhiray
18:57
Masterclasses in Dermatology

Safety and Monitoring Considerations in Systematic Therapy

Feat. J. Cohen
09:51
i3 Health

MRD Testing in Leukemias: When Negativity Is a Positive Thing

Feat. N. S. Raje
14:39
Penn Medicine's 2024 Updates in Care of the Hematologic Malignancies Patient

Immunotherapies in Acute Leukemias: 2024 Update

Feat. C. Lai
23:15
Rush University Medical Center

Is Post-HSCT Maintenance the SOC for AML?

Feat. M. Levis
09:42
2024 ASCO® Annual Meeting Insights Hub

ASCO® 2024 Insights: "Post-Transplant Cyclophosphamide-Based Gv…

Feat. M. Al Malki
16:28
Fred Hutchinson Cancer Center

Blinatumomab for Ph- ALL in First MRD-Negative Remission: E1910 and …

Feat. R. Cassaday
13:26
Steven Pavletic

Chronic GvHD: Main Complications After ASCT

28:33
XIV Eurasian Hematology-Oncology Congress - EHOC 2023

The Truth About Current Consensus Statements on Hematopoietic Cell T…

Feat. R. Gale
31:41
MyCancerHaven

Treating Adults With Newly Diagnosed ALL

Feat. R. Vij, A. Patel
04:02
Michael Burke

Updated Results from the BLAST and TOWER Studies: Safety and Efficac…

28:07
Indy Hematology Review

Controversies and Recommendations for the Treatment of ALL and Lymph…

Feat. W. Stock
40:21
Fred Hutch 13th Annual Comprehensive Hematology & Oncology Review Course

Overview of Hematopoietic Cell Transplantation

Feat. R. Salit
01:29
Incyte

Targeting CSF-1R to Manage Inflammation and Fibrosis in GVHD